We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Sensitive Assay Differentiates Human Papillomavirus

By LabMedica International staff writers
Posted on 28 Jun 2012
A real-time polymerase chain reaction assay detects Human Papillomavirus (HPV) enabling discrimination of all high-risk HPV types in a clinical high-throughput setting. More...


This real-time quantitative polymerase chain reaction assay (qPCR) can be routinely applied in a liquid-based cytology screening setting and can be used in many epidemiological and clinical studies.

Scientists at the University of Antwerp (Belgium) have described the laboratory workflow and the validation of a type-specific qPCR assay for high-throughput HPV detection, genotyping, and quantification. The optimization of each multiplex PCR was based on plasmids for each HPV type and female human DNA. Numerous trials were performed to evaluate the primers, probes, fluorochromes, cycling parameters and the effect of background DNA.

DNA was extracted from cervical cells that had been collected into the ethanol-based preservative Surepath TM (Tripath Imaging; Burlington, NC, USA) using the Cervex-Brush (Rovers Medical Devices B.V.; KV Oss, The Netherlands), and after manipulation, the DNA was amplified in the LightCycler 480 thermocycler (Roche Applied Science; Basel, Switzerland).

The TaqMan-based qPCR assay enables the detection of 17 HPV genotypes and beta-globin in seven multiplex reactions. These HPV types include all 12 high-risk types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59), three probably high-risk types (HPV53, 66 and 68), one low-risk type (HPV6) and one undetermined risk type (HPV67). The analytical sensitivity of less than 100 copies was obtained for all the HPV types. The analytical specificity of each primer pair was 100% and an intra- and inter-run variability of less than 6.4% was observed.

Worldwide, cervical cancer is the third most common female cancer. In Western Europe, it is only the 15th most common cause of cancer death in women as a result of cytology-based screening. However, the efficacy of cytological screening is hampered by the high inter-observer variability and high false positive and false-negative rates. The authors concluded that the type-specific real-time PCR approach enables detection of 17 HPV types, identification of the HPV type and determination of the viral load in a single sensitive assay suitable for high-throughput screening. The study was published online on April 5, 2012, in the journal Clinical Chemistry and Laboratory Medicine.

Related Links:

University of Antwerp
Rovers Medical Devices
Roche Applied Science



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.